Location: Home
  • search
  • go
  • Relate News
  • 5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
  • 5/31/2025Recent Official and Executive Moves
  • 5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED
  • 5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China
  • 5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...
  • 5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China
  • 5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...
  • 5/29/2025China Grants Conditional Approval to Hengrui's Famitinib
  • 5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million
  • 5/28/2025Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...
  • 5/28/2025Vigene and Merz Expand Strategic Partnership Across Greater China
  • 5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...
  • 5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939
  • 5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...
  • 5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova
  • 5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...
  • 5/27/2025RemeGen's Telitacicept Gains Approval in China
  • 5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia
  • 5/23/2025Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...
  • 5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China
  • 5/23/2025Recent Executive Moves
  • 5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD
  • 5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo
  • 5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL
  • 5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports
  • 5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare
  • 5/20/2025Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
  • 5/20/2025Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
  • 5/20/2025JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
  • 5/20/2025WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
  • Page:10/367 Total number of articles:10986: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group